|
|
|
HB0445 Enrolled |
|
LRB096 04780 RLC 14844 b |
|
|
1 |
| AN ACT concerning criminal law.
|
2 |
| Be it enacted by the People of the State of Illinois,
|
3 |
| represented in the General Assembly:
|
4 |
| Section 5. The Illinois Controlled Substances Act is |
5 |
| amended by changing Sections 204, 401, and 402 as follows:
|
6 |
| (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
|
7 |
| Sec. 204. (a) The controlled substances listed in this |
8 |
| Section are
included in Schedule I.
|
9 |
| (b) Unless specifically excepted or unless listed in |
10 |
| another
schedule, any of the following opiates, including their |
11 |
| isomers,
esters, ethers, salts, and salts of isomers, esters, |
12 |
| and ethers,
whenever the existence of such isomers, esters, |
13 |
| ethers and salts is
possible within the specific chemical |
14 |
| designation:
|
15 |
| (1) Acetylmethadol;
|
16 |
| (1.1) Acetyl-alpha-methylfentanyl
|
17 |
| (N-[1-(1-methyl-2-phenethyl)-
|
18 |
| 4-piperidinyl]-N-phenylacetamide);
|
19 |
| (2) Allylprodine;
|
20 |
| (3) Alphacetylmethadol, except
|
21 |
| levo-alphacetylmethadol (also known as levo-alpha-
|
22 |
| acetylmethadol, levomethadyl acetate, or LAAM);
|
23 |
| (4) Alphameprodine;
|
|
|
|
HB0445 Enrolled |
- 3 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (20) Dimethylthiambutene;
|
2 |
| (21) Dioxaphetylbutyrate;
|
3 |
| (22) Dipipanone;
|
4 |
| (23) Ethylmethylthiambutene;
|
5 |
| (24) Etonitazene;
|
6 |
| (25) Etoxeridine;
|
7 |
| (26) Furethidine;
|
8 |
| (27) Hydroxpethidine;
|
9 |
| (28) Ketobemidone;
|
10 |
| (29) Levomoramide;
|
11 |
| (30) Levophenacylmorphan;
|
12 |
| (31) 3-Methylfentanyl
|
13 |
| (N-[3-methyl-1-(2-phenylethyl)-
|
14 |
| 4-piperidyl]-N-phenylpropanamide);
|
15 |
| (31.1) 3-Methylthiofentanyl
|
16 |
| (N-[(3-methyl-1-(2-thienyl)ethyl-
|
17 |
| 4-piperidinyl]-N-phenylpropanamide);
|
18 |
| (32) Morpheridine;
|
19 |
| (33) Noracymethadol;
|
20 |
| (34) Norlevorphanol;
|
21 |
| (35) Normethadone;
|
22 |
| (36) Norpipanone;
|
23 |
| (36.1) Para-fluorofentanyl
|
24 |
| (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
|
25 |
| 4-piperidinyl]propanamide);
|
26 |
| (37) Phenadoxone;
|
|
|
|
HB0445 Enrolled |
- 4 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (38) Phenampromide;
|
2 |
| (39) Phenomorphan;
|
3 |
| (40) Phenoperidine;
|
4 |
| (41) Piritramide;
|
5 |
| (42) Proheptazine;
|
6 |
| (43) Properidine;
|
7 |
| (44) Propiram;
|
8 |
| (45) Racemoramide;
|
9 |
| (45.1) Thiofentanyl
|
10 |
| (N-phenyl-N-[1-(2-thienyl)ethyl-
|
11 |
| 4-piperidinyl]-propanamide);
|
12 |
| (46) Tilidine;
|
13 |
| (47) Trimeperidine;
|
14 |
| (48) Beta-hydroxy-3-methylfentanyl (other name:
|
15 |
| N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
|
16 |
| N-phenylpropanamide).
|
17 |
| (c) Unless specifically excepted or unless listed in |
18 |
| another
schedule, any of the following opium derivatives, its |
19 |
| salts, isomers
and salts of isomers, whenever the existence of |
20 |
| such salts, isomers and
salts of isomers is possible within the |
21 |
| specific chemical designation:
|
22 |
| (1) Acetorphine;
|
23 |
| (2) Acetyldihydrocodeine;
|
24 |
| (3) Benzylmorphine;
|
25 |
| (4) Codeine methylbromide;
|
26 |
| (5) Codeine-N-Oxide;
|
|
|
|
HB0445 Enrolled |
- 5 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (6) Cyprenorphine;
|
2 |
| (7) Desomorphine;
|
3 |
| (8) Diacetyldihydromorphine (Dihydroheroin);
|
4 |
| (9) Dihydromorphine;
|
5 |
| (10) Drotebanol;
|
6 |
| (11) Etorphine (except hydrochloride salt);
|
7 |
| (12) Heroin;
|
8 |
| (13) Hydromorphinol;
|
9 |
| (14) Methyldesorphine;
|
10 |
| (15) Methyldihydromorphine;
|
11 |
| (16) Morphine methylbromide;
|
12 |
| (17) Morphine methylsulfonate;
|
13 |
| (18) Morphine-N-Oxide;
|
14 |
| (19) Myrophine;
|
15 |
| (20) Nicocodeine;
|
16 |
| (21) Nicomorphine;
|
17 |
| (22) Normorphine;
|
18 |
| (23) Pholcodine;
|
19 |
| (24) Thebacon.
|
20 |
| (d) Unless specifically excepted or unless listed in |
21 |
| another
schedule, any material, compound, mixture, or |
22 |
| preparation which contains
any quantity of the following |
23 |
| hallucinogenic substances, or which
contains any of its salts, |
24 |
| isomers and salts of isomers, whenever the
existence of such |
25 |
| salts, isomers, and salts of isomers is possible
within the |
26 |
| specific chemical designation (for the purposes of this
|
|
|
|
HB0445 Enrolled |
- 6 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| paragraph only, the term "isomer" includes the optical, |
2 |
| position and
geometric isomers):
|
3 |
| (1) 3,4-methylenedioxyamphetamine
|
4 |
| (alpha-methyl,3,4-methylenedioxyphenethylamine,
|
5 |
| methylenedioxyamphetamine, MDA);
|
6 |
| (1.1) Alpha-ethyltryptamine
|
7 |
| (some trade or other names: etryptamine;
|
8 |
| MONASE; alpha-ethyl-1H-indole-3-ethanamine;
|
9 |
| 3-(2-aminobutyl)indole; a-ET; and AET);
|
10 |
| (2) 3,4-methylenedioxymethamphetamine (MDMA);
|
11 |
| (2.1) 3,4-methylenedioxy-N-ethylamphetamine
|
12 |
| (also known as: N-ethyl-alpha-methyl-
|
13 |
| 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
|
14 |
| and MDEA);
|
15 |
| (2.2) N-Benzylpiperazine (BZP);
|
16 |
| (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
|
17 |
| (4) 3,4,5-trimethoxyamphetamine (TMA);
|
18 |
| (5) (Blank);
|
19 |
| (6) Diethyltryptamine (DET);
|
20 |
| (7) Dimethyltryptamine (DMT);
|
21 |
| (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
|
22 |
| (9) Ibogaine (some trade and other names:
|
23 |
| 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
|
24 |
| 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
|
25 |
| indole; Tabernanthe iboga);
|
26 |
| (10) Lysergic acid diethylamide;
|
|
|
|
HB0445 Enrolled |
- 7 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (10.5) Salvia divinorum (meaning all parts of the plant |
2 |
| presently classified
botanically as Salvia divinorum, |
3 |
| whether growing or not, the
seeds thereof, any extract from |
4 |
| any part of that plant, and every compound,
manufacture, |
5 |
| salts, isomers, and salts of
isomers whenever the existence |
6 |
| of such salts, isomers, and salts of
isomers is possible |
7 |
| within the specific chemical designation, derivative, |
8 |
| mixture, or preparation of that plant, its
seeds or |
9 |
| extracts);
|
10 |
| (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
|
11 |
| (12) Peyote (meaning all parts of the plant presently |
12 |
| classified
botanically as Lophophora williamsii
Lemaire, |
13 |
| whether growing or not, the
seeds thereof, any extract from |
14 |
| any part of that plant, and every compound,
manufacture, |
15 |
| salts, derivative, mixture, or preparation of that plant, |
16 |
| its
seeds or extracts);
|
17 |
| (13) N-ethyl-3-piperidyl benzilate (JB 318);
|
18 |
| (14) N-methyl-3-piperidyl benzilate;
|
19 |
| (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
|
20 |
| (also known as N-hydroxy-alpha-methyl-
|
21 |
| 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
|
22 |
| (15) Parahexyl; some trade or other names:
|
23 |
| 3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
|
24 |
| dibenzo (b,d) pyran; Synhexyl;
|
25 |
| (16) Psilocybin;
|
26 |
| (17) Psilocyn;
|
|
|
|
HB0445 Enrolled |
- 8 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (18) Alpha-methyltryptamine (AMT);
|
2 |
| (19) 2,5-dimethoxyamphetamine
|
3 |
| (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
|
4 |
| (20) 4-bromo-2,5-dimethoxyamphetamine
|
5 |
| (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
|
6 |
| 4-bromo-2,5-DMA);
|
7 |
| (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
|
8 |
| Some trade or other names: 2-(4-bromo-
|
9 |
| 2,5-dimethoxyphenyl)-1-aminoethane;
|
10 |
| alpha-desmethyl DOB, 2CB, Nexus;
|
11 |
| (21) 4-methoxyamphetamine
|
12 |
| (4-methoxy-alpha-methylphenethylamine;
|
13 |
| paramethoxyamphetamine; PMA);
|
14 |
| (22) (Blank);
|
15 |
| (23) Ethylamine analog of phencyclidine.
|
16 |
| Some trade or other names:
|
17 |
| N-ethyl-1-phenylcyclohexylamine,
|
18 |
| (1-phenylcyclohexyl) ethylamine,
|
19 |
| N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
|
20 |
| (24) Pyrrolidine analog of phencyclidine. Some trade |
21 |
| or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, |
22 |
| PHP;
|
23 |
| (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
|
24 |
| (26) 2,5-dimethoxy-4-ethylamphetamine
|
25 |
| (another name: DOET);
|
26 |
| (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
|
|
|
HB0445 Enrolled |
- 9 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (another name: TCPy);
|
2 |
| (28) (Blank);
|
3 |
| (29) Thiophene analog of phencyclidine (some trade
|
4 |
| or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
|
5 |
| 2-thienyl analog of phencyclidine; TPCP; TCP);
|
6 |
| (30) Bufotenine (some trade or other names:
|
7 |
| 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
|
8 |
| 3-(2-dimethylaminoethyl)-5-indolol;
|
9 |
| 5-hydroxy-N,N-dimethyltryptamine;
|
10 |
| N,N-dimethylserotonin; mappine).
|
11 |
| (e) Unless specifically excepted or unless listed in |
12 |
| another
schedule, any material, compound, mixture, or |
13 |
| preparation which contains
any quantity of the following |
14 |
| substances having a depressant effect on
the central nervous |
15 |
| system, including its salts, isomers, and salts of
isomers |
16 |
| whenever the existence of such salts, isomers, and salts of
|
17 |
| isomers is possible within the specific chemical designation:
|
18 |
| (1) mecloqualone;
|
19 |
| (2) methaqualone; and
|
20 |
| (3) gamma hydroxybutyric acid.
|
21 |
| (f) Unless specifically excepted or unless listed in |
22 |
| another schedule,
any material, compound, mixture, or |
23 |
| preparation which contains any quantity
of the following |
24 |
| substances having a stimulant effect on the central nervous
|
25 |
| system, including its salts, isomers, and salts of isomers:
|
26 |
| (1) Fenethylline;
|
|
|
|
HB0445 Enrolled |
- 10 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (2) N-ethylamphetamine;
|
2 |
| (3) Aminorex (some other names:
|
3 |
| 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
|
4 |
| 4-5-dihydro-5-phenyl-2-oxazolamine) and its
|
5 |
| salts, optical isomers, and salts of optical isomers;
|
6 |
| (4) Methcathinone (some other names:
|
7 |
| 2-methylamino-1-phenylpropan-1-one;
|
8 |
| Ephedrone; 2-(methylamino)-propiophenone;
|
9 |
| alpha-(methylamino)propiophenone; N-methylcathinone;
|
10 |
| methycathinone; Monomethylpropion; UR 1431) and its
|
11 |
| salts, optical isomers, and salts of optical isomers;
|
12 |
| (5) Cathinone (some trade or other names:
|
13 |
| 2-aminopropiophenone; alpha-aminopropiophenone;
|
14 |
| 2-amino-1-phenyl-propanone; norephedrone);
|
15 |
| (6) N,N-dimethylamphetamine (also known as:
|
16 |
| N,N-alpha-trimethyl-benzeneethanamine;
|
17 |
| N,N-alpha-trimethylphenethylamine);
|
18 |
| (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
|
19 |
| 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
|
20 |
| (g) Temporary listing of substances subject to emergency |
21 |
| scheduling.
Any material, compound, mixture, or preparation |
22 |
| that contains any quantity
of the following substances:
|
23 |
| (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
|
24 |
| (benzylfentanyl), its optical isomers, isomers, salts,
|
25 |
| and salts of isomers;
|
26 |
| (2) N-[1(2-thienyl)
|
|
|
|
HB0445 Enrolled |
- 11 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
|
2 |
| its optical isomers, salts, and salts of isomers.
|
3 |
| (Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07.)
|
4 |
| (720 ILCS 570/401) (from Ch. 56 1/2, par. 1401)
|
5 |
| Sec. 401. Except as authorized by this Act, it is unlawful |
6 |
| for any
person knowingly to manufacture or deliver, or possess |
7 |
| with intent to
manufacture or deliver, a controlled substance |
8 |
| other than methamphetamine, a counterfeit substance, or a |
9 |
| controlled
substance analog. A violation of this Act with |
10 |
| respect to each of the controlled
substances listed herein |
11 |
| constitutes a single and separate violation of this
Act. For |
12 |
| purposes of this Section, "controlled substance analog" or |
13 |
| "analog"
means a substance
which is intended for human |
14 |
| consumption, other than a controlled substance,
that has a |
15 |
| chemical structure substantially similar to that of a |
16 |
| controlled
substance in Schedule I or II, or that was |
17 |
| specifically designed to produce
an effect substantially |
18 |
| similar to that of a controlled substance in Schedule
I or II. |
19 |
| Examples of chemical classes in which controlled substance |
20 |
| analogs
are found include, but are not limited to, the |
21 |
| following: phenethylamines,
N-substituted piperidines, |
22 |
| morphinans, ecgonines, quinazolinones, substituted
indoles, |
23 |
| and arylcycloalkylamines. For purposes of this Act, a |
24 |
| controlled
substance analog shall be treated in the same manner |
25 |
| as the controlled
substance to which it is substantially |
|
|
|
HB0445 Enrolled |
- 12 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| similar.
|
2 |
| (a) Any person who violates this Section with respect to |
3 |
| the following
amounts of controlled or counterfeit substances |
4 |
| or controlled substance
analogs, notwithstanding any of the |
5 |
| provisions of subsections (c),
(d), (e), (f), (g) or (h) to the |
6 |
| contrary, is guilty of a Class X felony
and shall be sentenced |
7 |
| to a term of imprisonment as provided in this subsection
(a) |
8 |
| and fined as provided in subsection (b):
|
9 |
| (1) (A) not less than 6 years and not more than 30 |
10 |
| years with respect
to 15 grams or more but less than |
11 |
| 100 grams of a substance containing
heroin, or an |
12 |
| analog thereof;
|
13 |
| (B) not less than 9 years and not more than 40 |
14 |
| years with respect to 100
grams or more but less than |
15 |
| 400 grams of a substance containing heroin, or
an |
16 |
| analog thereof;
|
17 |
| (C) not less than 12 years and not more than 50 |
18 |
| years with respect to
400 grams or more but less than |
19 |
| 900 grams of a substance containing heroin,
or an |
20 |
| analog thereof;
|
21 |
| (D) not less than 15 years and not more than 60 |
22 |
| years with respect to
900 grams or more of any |
23 |
| substance containing heroin, or an analog thereof;
|
24 |
| (1.5) (A) not less than 6 years and not more than 30 |
25 |
| years with respect to 15 grams or more but less than |
26 |
| 100 grams of a substance containing fentanyl, or an |
|
|
|
HB0445 Enrolled |
- 13 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| analog thereof;
|
2 |
| (B) not less than 9 years and not more than 40 |
3 |
| years with respect to 100 grams or more but less than |
4 |
| 400 grams of a substance containing fentanyl, or an |
5 |
| analog thereof; |
6 |
| (C) not less than 12 years and not more than 50 |
7 |
| years with respect to 400 grams or more but less than |
8 |
| 900 grams of a substance containing fentanyl, or an |
9 |
| analog thereof; |
10 |
| (D) not less than 15 years and not more than 60 |
11 |
| years with respect to 900 grams or more of a substance |
12 |
| containing fentanyl, or an analog thereof;
|
13 |
| (2) (A) not less than 6 years and not more than 30 |
14 |
| years with respect
to 15 grams or more but less than |
15 |
| 100 grams of a substance containing
cocaine, or an |
16 |
| analog thereof;
|
17 |
| (B) not less than 9 years and not more than 40 |
18 |
| years with respect to 100
grams or more but less than |
19 |
| 400 grams of a substance containing cocaine, or
an |
20 |
| analog thereof;
|
21 |
| (C) not less than 12 years and not more than 50 |
22 |
| years with respect to
400 grams or more but less than |
23 |
| 900 grams of a substance containing cocaine,
or an |
24 |
| analog thereof;
|
25 |
| (D) not less than 15 years and not more than 60 |
26 |
| years with respect to
900 grams or more of any |
|
|
|
HB0445 Enrolled |
- 14 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| substance containing cocaine, or an analog thereof;
|
2 |
| (3) (A) not less than 6 years and not more than 30 |
3 |
| years with respect
to 15 grams or more but less than |
4 |
| 100 grams of a substance containing
morphine, or an |
5 |
| analog thereof;
|
6 |
| (B) not less than 9 years and not more than 40 |
7 |
| years with respect to
100 grams or more but less than |
8 |
| 400 grams of a substance containing morphine,
or an |
9 |
| analog thereof;
|
10 |
| (C) not less than 12 years and not more than 50 |
11 |
| years with respect to
400 grams or more but less than |
12 |
| 900 grams of a substance containing
morphine, or an |
13 |
| analog thereof;
|
14 |
| (D) not less than 15 years and not more than 60 |
15 |
| years with respect to
900 grams or more of a substance |
16 |
| containing morphine, or an analog thereof;
|
17 |
| (4) 200 grams or more of any substance containing |
18 |
| peyote, or an
analog thereof;
|
19 |
| (5) 200 grams or more of any substance containing a |
20 |
| derivative of
barbituric acid or any of the salts of a |
21 |
| derivative of barbituric acid, or
an analog thereof;
|
22 |
| (6) 200 grams or more of any substance containing |
23 |
| amphetamine
or any salt of an optical isomer of |
24 |
| amphetamine,
or an analog thereof;
|
25 |
| (6.5) (blank);
|
26 |
| (6.6) (blank);
|
|
|
|
HB0445 Enrolled |
- 15 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (7) (A) not less than 6 years and not more than 30 |
2 |
| years with respect
to: (i) 15 grams or more but less |
3 |
| than 100 grams of a substance containing
lysergic acid |
4 |
| diethylamide (LSD), or an analog thereof, or (ii) 15 or
|
5 |
| more objects or 15 or more segregated parts of an |
6 |
| object or objects but
less than 200 objects or 200 |
7 |
| segregated parts of an object or objects
containing in |
8 |
| them or having upon them any amounts of any substance
|
9 |
| containing lysergic acid diethylamide (LSD), or an |
10 |
| analog thereof;
|
11 |
| (B) not less than 9 years and not more than 40 |
12 |
| years with respect
to: (i) 100 grams or more but less |
13 |
| than 400 grams of a substance containing
lysergic acid |
14 |
| diethylamide (LSD), or an analog thereof, or (ii) 200 |
15 |
| or more
objects or 200 or more segregated parts of an |
16 |
| object or objects but less
than 600 objects or less |
17 |
| than 600 segregated parts of an object or objects
|
18 |
| containing in them or having upon them any amount of |
19 |
| any substance
containing lysergic acid diethylamide |
20 |
| (LSD), or an analog thereof;
|
21 |
| (C) not less than 12 years and not more than 50 |
22 |
| years with respect
to: (i) 400 grams or more but less |
23 |
| than 900 grams of a substance containing
lysergic acid |
24 |
| diethylamide (LSD), or an analog thereof, or (ii) 600 |
25 |
| or more
objects or 600 or more segregated parts of an |
26 |
| object or objects but less
than 1500 objects or 1500 |
|
|
|
HB0445 Enrolled |
- 16 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| segregated parts of an object or objects
containing in |
2 |
| them or having upon them any amount of any substance
|
3 |
| containing lysergic acid diethylamide (LSD), or an |
4 |
| analog thereof;
|
5 |
| (D) not less than 15 years and not more than 60 |
6 |
| years with respect
to: (i) 900 grams or more of any |
7 |
| substance containing lysergic acid
diethylamide (LSD), |
8 |
| or an analog thereof, or (ii) 1500 or more objects or
|
9 |
| 1500 or more segregated parts of an object or objects |
10 |
| containing in them or
having upon them any amount of a |
11 |
| substance containing lysergic acid
diethylamide (LSD), |
12 |
| or an analog thereof;
|
13 |
| (7.5) (A) not less than 6 years and not more than 30 |
14 |
| years with respect
to:
(i) 15
grams or more but less |
15 |
| than 100 grams of a substance listed in paragraph (1),
|
16 |
| (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), |
17 |
| (21), (25), or (26) of subsection
(d) of Section 204, |
18 |
| or an analog or derivative thereof, or (ii) 15 or more
|
19 |
| pills, tablets, caplets, capsules, or objects but less |
20 |
| than 200 pills, tablets,
caplets, capsules, or objects |
21 |
| containing in them or having upon them any
amounts of |
22 |
| any substance listed in paragraph (1), (2), (2.1), |
23 |
| (2.2), (3), (14.1),
(19), (20), (20.1), (21), (25), or |
24 |
| (26) of subsection (d) of Section 204, or
an analog or |
25 |
| derivative thereof;
|
26 |
| (B) not less than 9 years and not more than 40 |
|
|
|
HB0445 Enrolled |
- 17 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| years with respect to:
(i) 100 grams or more but less |
2 |
| than 400 grams of a substance listed in
paragraph (1), |
3 |
| (2), (2.1), (2.2), (3), (14.1), (19), (20),
(20.1), |
4 |
| (21), (25), or (26) of subsection (d) of Section 204, |
5 |
| or an analog or
derivative thereof, or (ii) 200 or more |
6 |
| pills, tablets, caplets, capsules, or
objects but less |
7 |
| than 600 pills, tablets, caplets, capsules, or objects
|
8 |
| containing in them or having upon them any amount of |
9 |
| any substance listed in
paragraph (1), (2), (2.1), |
10 |
| (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or |
11 |
| (26)
of subsection (d) of Section 204, or an analog or |
12 |
| derivative thereof;
|
13 |
| (C) not less than 12 years and not more than 50 |
14 |
| years with respect to:
(i) 400 grams or more but less |
15 |
| than 900 grams of a substance listed in
paragraph (1), |
16 |
| (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1), |
17 |
| (21), (25), or (26)
of subsection (d) of Section 204, |
18 |
| or an analog or derivative thereof,
or (ii) 600 or more |
19 |
| pills, tablets, caplets, capsules, or objects but less |
20 |
| than
1,500 pills, tablets, caplets, capsules, or |
21 |
| objects
containing in them or having upon them any |
22 |
| amount of any substance listed in
paragraph (1), (2), |
23 |
| (2.1), (2.2), (3), (14.1), (19), (20), (20.1), (21), |
24 |
| (25), or (26)
of subsection (d) of Section 204, or an |
25 |
| analog or derivative thereof;
|
26 |
| (D) not less than 15 years and not more than 60 |
|
|
|
HB0445 Enrolled |
- 18 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| years with respect to:
(i) 900 grams or more of any |
2 |
| substance listed in paragraph (1), (2), (2.1),
(2.2), |
3 |
| (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of |
4 |
| subsection (d) of
Section 204, or an analog or |
5 |
| derivative thereof, or (ii) 1,500 or more pills,
|
6 |
| tablets, caplets, capsules, or objects containing in |
7 |
| them or having upon them
any amount
of a substance |
8 |
| listed in paragraph (1), (2), (2.1), (2.2), (3), |
9 |
| (14.1), (19),
(20), (20.1), (21), (25), or (26)
of |
10 |
| subsection (d) of Section 204, or an analog or |
11 |
| derivative thereof;
|
12 |
| (8) 30 grams or more of any substance containing |
13 |
| pentazocine or any of
the salts, isomers and salts of |
14 |
| isomers of pentazocine, or an analog thereof;
|
15 |
| (9) 30 grams or more of any substance containing |
16 |
| methaqualone or any of
the salts, isomers and salts of |
17 |
| isomers of methaqualone, or an analog thereof;
|
18 |
| (10) 30 grams or more of any substance containing |
19 |
| phencyclidine or any
of the salts, isomers and salts of |
20 |
| isomers of phencyclidine (PCP),
or an analog thereof;
|
21 |
| (10.5) 30 grams or more of any substance containing |
22 |
| ketamine
or any of the salts, isomers and salts of isomers |
23 |
| of ketamine,
or an analog thereof;
|
24 |
| (11) 200 grams or more of any substance containing any |
25 |
| other controlled
substance classified in Schedules I or II, |
26 |
| or an analog thereof, which is
not otherwise included in |
|
|
|
HB0445 Enrolled |
- 19 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| this subsection.
|
2 |
| (b) Any person sentenced with respect to violations of |
3 |
| paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) |
4 |
| involving
100 grams or
more of the
controlled substance named |
5 |
| therein, may in addition to the penalties
provided therein, be |
6 |
| fined an amount not more than $500,000 or the full
street value |
7 |
| of the controlled or counterfeit substance or controlled |
8 |
| substance
analog, whichever is greater. The term "street value" |
9 |
| shall have the
meaning ascribed in Section 110-5 of the Code of |
10 |
| Criminal Procedure of
1963. Any person sentenced with respect |
11 |
| to any other provision of
subsection (a), may in addition to |
12 |
| the penalties provided therein, be fined
an amount not to |
13 |
| exceed $500,000. |
14 |
| (b-1) Excluding violations of this Act when the controlled |
15 |
| substance is fentanyl, any person sentenced to a term of |
16 |
| imprisonment with respect to violations of Section 401, 401.1, |
17 |
| 405, 405.1, 405.2, or 407, when the substance containing the |
18 |
| controlled substance contains any amount of fentanyl, 3 years |
19 |
| shall be added to the term of imprisonment imposed by the |
20 |
| court, and the maximum sentence for the offense shall be |
21 |
| increased by 3 years.
|
22 |
| (c) Any person who violates this Section with regard to the
|
23 |
| following amounts of controlled or counterfeit substances
or |
24 |
| controlled substance analogs, notwithstanding any of the |
25 |
| provisions of
subsections (a), (b), (d), (e), (f), (g) or (h) |
26 |
| to the
contrary, is guilty of a Class 1 felony. The fine for |
|
|
|
HB0445 Enrolled |
- 20 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| violation of this
subsection (c) shall not be more than |
2 |
| $250,000:
|
3 |
| (1) 1 gram or more but less than 15 grams of any
|
4 |
| substance containing heroin, or an analog thereof;
|
5 |
| (1.5) 1 gram or more but less than 15 grams of any |
6 |
| substance containing fentanyl, or an analog thereof;
|
7 |
| (2) 1 gram or more but less than 15
grams of any |
8 |
| substance containing cocaine, or an analog thereof;
|
9 |
| (3) 10 grams or more but less than 15 grams of any |
10 |
| substance
containing morphine, or an analog thereof;
|
11 |
| (4) 50 grams or more but less than 200 grams of any |
12 |
| substance
containing peyote, or an analog thereof;
|
13 |
| (5) 50 grams or more but less than 200 grams of any |
14 |
| substance
containing a derivative of barbituric acid or any |
15 |
| of the salts of a
derivative of barbituric acid, or an |
16 |
| analog thereof;
|
17 |
| (6) 50 grams or more but less than 200 grams of any |
18 |
| substance
containing amphetamine or any salt of an optical |
19 |
| isomer
of amphetamine, or an analog thereof;
|
20 |
| (6.5) (blank);
|
21 |
| (7) (i) 5 grams or more but less than 15 grams of any |
22 |
| substance
containing lysergic acid diethylamide (LSD), or |
23 |
| an analog thereof,
or (ii)
more than 10 objects or more |
24 |
| than 10 segregated parts of an object or objects
but less |
25 |
| than 15 objects or less than 15 segregated parts of an |
26 |
| object
containing in them or having upon them any amount of |
|
|
|
HB0445 Enrolled |
- 21 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| any substance
containing lysergic acid diethylamide (LSD), |
2 |
| or an analog thereof;
|
3 |
| (7.5) (i) 5 grams or more but less than 15 grams of any |
4 |
| substance listed
in paragraph (1), (2), (2.1), (2.2), (3), |
5 |
| (14.1), (19), (20), (20.1), (21), (25), or
(26) of |
6 |
| subsection (d) of Section 204, or an analog or derivative |
7 |
| thereof, or
(ii) more than 10 pills, tablets, caplets, |
8 |
| capsules, or objects but less than
15 pills, tablets, |
9 |
| caplets, capsules, or objects containing in them or having
|
10 |
| upon them any amount of any substance listed in paragraph |
11 |
| (1), (2), (2.1),
(2.2), (3), (14.1), (19), (20), (20.1), |
12 |
| (21), (25), or (26) of subsection (d) of
Section 204, or an |
13 |
| analog or derivative thereof;
|
14 |
| (8) 10 grams or more but less than 30 grams of any |
15 |
| substance
containing pentazocine or any of the salts, |
16 |
| isomers and salts of isomers of
pentazocine, or an analog |
17 |
| thereof;
|
18 |
| (9) 10 grams or more but less than 30 grams of any |
19 |
| substance
containing methaqualone or any of the salts, |
20 |
| isomers and salts of isomers
of methaqualone, or an analog |
21 |
| thereof;
|
22 |
| (10) 10 grams or more but less than 30 grams of any |
23 |
| substance
containing phencyclidine or any of the salts, |
24 |
| isomers and salts of isomers
of phencyclidine (PCP), or an |
25 |
| analog thereof;
|
26 |
| (10.5) 10 grams or more but less than 30 grams of any |
|
|
|
HB0445 Enrolled |
- 22 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| substance
containing ketamine or any of the salts, isomers |
2 |
| and salts of
isomers of ketamine, or an analog thereof;
|
3 |
| (11) 50 grams or more but less than 200 grams of any |
4 |
| substance
containing a substance classified in Schedules I |
5 |
| or II, or an analog
thereof, which is not otherwise |
6 |
| included in this subsection.
|
7 |
| (c-5) (Blank).
|
8 |
| (d) Any person who violates this Section with regard to any |
9 |
| other
amount of a controlled or counterfeit substance |
10 |
| classified in
Schedules I or II, or an analog thereof, which is |
11 |
| (i) a narcotic
drug, (ii) lysergic acid diethylamide (LSD) or |
12 |
| an analog thereof, or
(iii) any
substance containing |
13 |
| amphetamine or fentanyl or any salt or optical
isomer of |
14 |
| amphetamine or fentanyl, or an analog thereof, or (iv) any
|
15 |
| substance containing N-Benzylpiperazine (BZP) or any salt or |
16 |
| optical
isomer of N-Benzylpiperazine (BZP), or an analog |
17 |
| thereof, is guilty
of a Class 2 felony. The fine for violation |
18 |
| of this subsection (d) shall
not be more than $200,000.
|
19 |
| (d-5) (Blank).
|
20 |
| (e) Any person who violates this Section with regard to any |
21 |
| other
amount of a controlled substance other than |
22 |
| methamphetamine or counterfeit substance classified in
|
23 |
| Schedule I or II, or an analog thereof, which substance is not
|
24 |
| included under subsection (d) of this Section, is
guilty of a |
25 |
| Class 3 felony. The fine for violation of this subsection (e)
|
26 |
| shall not be more than $150,000.
|
|
|
|
HB0445 Enrolled |
- 23 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (f) Any person who violates this Section with regard to any |
2 |
| other
amount of a controlled or counterfeit substance |
3 |
| classified in
Schedule III is guilty of a Class 3 felony. The |
4 |
| fine for violation of
this subsection (f) shall not be more |
5 |
| than $125,000.
|
6 |
| (g) Any person who violates this Section with regard to any |
7 |
| other
amount of a controlled or counterfeit substance |
8 |
| classified
in Schedule IV is guilty of a Class 3 felony. The |
9 |
| fine for violation of
this subsection (g) shall not be more |
10 |
| than $100,000.
|
11 |
| (h) Any person who violates this Section with regard to any |
12 |
| other
amount of a controlled or counterfeit substance |
13 |
| classified in
Schedule V is guilty of a Class 3 felony. The |
14 |
| fine for violation of this
subsection (h) shall not be more |
15 |
| than $75,000.
|
16 |
| (i) This Section does not apply to the manufacture, |
17 |
| possession or
distribution of a substance in conformance with |
18 |
| the provisions of an approved
new drug application or an |
19 |
| exemption for investigational use within the
meaning of Section |
20 |
| 505 of the Federal Food, Drug and Cosmetic Act.
|
21 |
| (j) (Blank).
|
22 |
| (Source: P.A. 94-556, eff. 9-11-05; 95-259, eff. 8-17-07.)
|
23 |
| (720 ILCS 570/402) (from Ch. 56 1/2, par. 1402)
|
24 |
| Sec. 402. Except as otherwise authorized by this Act, it is |
25 |
| unlawful for
any person knowingly to possess a controlled or |
|
|
|
HB0445 Enrolled |
- 24 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| counterfeit substance or controlled substance analog.
A |
2 |
| violation of this Act with respect to each of the controlled |
3 |
| substances
listed herein constitutes a single and separate |
4 |
| violation of this Act. For purposes of this Section, |
5 |
| "controlled substance analog" or "analog"
means a substance
|
6 |
| which is intended for human consumption, other than a |
7 |
| controlled substance,
that has a chemical structure |
8 |
| substantially similar to that of a controlled
substance in |
9 |
| Schedule I or II, or that was specifically designed to produce
|
10 |
| an effect substantially similar to that of a controlled |
11 |
| substance in Schedule
I or II. Examples of chemical classes in |
12 |
| which controlled substance analogs
are found include, but are |
13 |
| not limited to, the following: phenethylamines,
N-substituted |
14 |
| piperidines, morphinans, ecgonines, quinazolinones, |
15 |
| substituted
indoles, and arylcycloalkylamines. For purposes of |
16 |
| this Act, a controlled
substance analog shall be treated in the |
17 |
| same manner as the controlled
substance to which it is |
18 |
| substantially similar.
|
19 |
| (a) Any person who violates this Section with respect to |
20 |
| the following
controlled or counterfeit substances and |
21 |
| amounts, notwithstanding any of the
provisions of subsections |
22 |
| (c) and (d) to the
contrary, is guilty of a Class 1 felony and |
23 |
| shall, if sentenced to a term
of imprisonment, be sentenced as |
24 |
| provided in this subsection (a) and fined
as provided in |
25 |
| subsection (b):
|
26 |
| (1) (A) not less than 4 years and not more than 15 |
|
|
|
HB0445 Enrolled |
- 25 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| years with respect
to 15 grams or more but less than |
2 |
| 100 grams of a substance containing heroin;
|
3 |
| (B) not less than 6 years and not more than 30 |
4 |
| years with respect to 100
grams or more but less than |
5 |
| 400 grams of a substance containing heroin;
|
6 |
| (C) not less than 8 years and not more than 40 |
7 |
| years with respect to 400
grams or more but less than |
8 |
| 900 grams of any substance containing heroin;
|
9 |
| (D) not less than 10 years and not more than 50 |
10 |
| years with respect to
900 grams or more of any |
11 |
| substance containing heroin;
|
12 |
| (2) (A) not less than 4 years and not more than 15 |
13 |
| years with respect
to 15 grams or more but less than |
14 |
| 100 grams of any substance containing
cocaine;
|
15 |
| (B) not less than 6 years and not more than 30 |
16 |
| years with respect to 100
grams or more but less than |
17 |
| 400 grams of any substance containing cocaine;
|
18 |
| (C) not less than 8 years and not more than 40 |
19 |
| years with respect to 400
grams or more but less than |
20 |
| 900 grams of any substance containing cocaine;
|
21 |
| (D) not less than 10 years and not more than 50 |
22 |
| years with respect to
900 grams or more of any |
23 |
| substance containing cocaine;
|
24 |
| (3) (A) not less than 4 years and not more than 15 |
25 |
| years with respect
to 15 grams or more but less than |
26 |
| 100 grams of any substance containing
morphine;
|
|
|
|
HB0445 Enrolled |
- 26 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (B) not less than 6 years and not more than 30 |
2 |
| years with respect to 100
grams or more but less than |
3 |
| 400 grams of any substance containing morphine;
|
4 |
| (C) not less than 6 years and not more than 40 |
5 |
| years with respect to 400
grams or more but less than |
6 |
| 900 grams of any substance containing morphine;
|
7 |
| (D) not less than 10 years and not more than 50 |
8 |
| years with respect to
900 grams or more of any |
9 |
| substance containing morphine;
|
10 |
| (4) 200 grams or more of any substance containing |
11 |
| peyote;
|
12 |
| (5) 200 grams or more of any substance containing a |
13 |
| derivative of
barbituric acid or any of the salts of a |
14 |
| derivative of barbituric acid;
|
15 |
| (6) 200 grams or more of any substance containing |
16 |
| amphetamine or any salt
of an optical isomer of |
17 |
| amphetamine;
|
18 |
| (6.5) (blank);
|
19 |
| (7) (A) not less than 4 years and not more than 15 |
20 |
| years with respect
to: (i) 15 grams or more but less |
21 |
| than 100 grams of any substance containing
lysergic |
22 |
| acid diethylamide (LSD), or an analog thereof, or (ii) |
23 |
| 15 or
more objects or 15 or more segregated parts of an |
24 |
| object or objects but
less than 200 objects or 200 |
25 |
| segregated parts of an object or objects
containing in |
26 |
| them or having upon them any amount of any substance
|
|
|
|
HB0445 Enrolled |
- 27 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| containing lysergic acid diethylamide (LSD), or an |
2 |
| analog thereof;
|
3 |
| (B) not less than 6 years and not more than 30 |
4 |
| years with respect
to: (i) 100 grams or more but less |
5 |
| than 400 grams of any substance
containing lysergic |
6 |
| acid diethylamide (LSD), or an analog thereof, or (ii)
|
7 |
| 200 or more objects or 200 or more segregated parts of |
8 |
| an object or objects
but less than 600 objects or less |
9 |
| than 600 segregated parts of an object or
objects |
10 |
| containing in them or having upon them any amount of |
11 |
| any substance
containing lysergic acid diethylamide |
12 |
| (LSD), or an analog thereof;
|
13 |
| (C) not less than 8 years and not more than 40 |
14 |
| years with respect
to: (i) 400 grams or more but less |
15 |
| than 900 grams of any substance
containing lysergic |
16 |
| acid diethylamide (LSD), or an analog thereof, or (ii)
|
17 |
| 600 or more objects or 600 or more segregated parts of |
18 |
| an object or objects
but less than 1500 objects or 1500 |
19 |
| segregated parts of an object or objects
containing in |
20 |
| them or having upon them any amount of any substance
|
21 |
| containing lysergic acid diethylamide (LSD), or an |
22 |
| analog thereof;
|
23 |
| (D) not less than 10 years and not more than 50 |
24 |
| years with respect
to: (i) 900 grams or more of any |
25 |
| substance containing lysergic acid
diethylamide (LSD), |
26 |
| or an analog thereof, or (ii) 1500 or more objects or
|
|
|
|
HB0445 Enrolled |
- 28 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| 1500 or more segregated parts of an object or objects |
2 |
| containing in them or
having upon them any amount of a |
3 |
| substance containing lysergic acid
diethylamide (LSD), |
4 |
| or an analog thereof;
|
5 |
| (7.5) (A) not less than 4 years and not more than 15 |
6 |
| years with respect
to: (i) 15
grams or more but
less |
7 |
| than 100 grams of any substance listed in paragraph |
8 |
| (1), (2), (2.1), (2.2), (3),
(14.1), (19),
(20), |
9 |
| (20.1), (21), (25), or (26) of subsection (d) of |
10 |
| Section 204, or an
analog or derivative
thereof, or |
11 |
| (ii) 15 or more pills, tablets, caplets, capsules, or |
12 |
| objects but
less than 200 pills,
tablets, caplets, |
13 |
| capsules, or objects containing in them or having upon |
14 |
| them
any amount of any
substance listed in paragraph |
15 |
| (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), |
16 |
| (20.1),
(21), (25), or (26) of
subsection (d) of |
17 |
| Section 204, or an analog or derivative thereof;
|
18 |
| (B) not less than 6 years and not more than 30 |
19 |
| years with respect to: (i)
100
grams or more but
less |
20 |
| than 400 grams of any substance listed in paragraph |
21 |
| (1), (2), (2.1), (2.2), (3),
(14.1), (19), (20),
|
22 |
| (20.1), (21), (25), or (26) of subsection (d) of |
23 |
| Section 204, or an analog or
derivative thereof, or
|
24 |
| (ii) 200 or more pills, tablets, caplets, capsules, or |
25 |
| objects but less than
600
pills, tablets,
caplets, |
26 |
| capsules, or objects containing in them or having upon |
|
|
|
HB0445 Enrolled |
- 29 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| them any amount
of any
substance
listed in paragraph |
2 |
| (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), |
3 |
| (20.1), (21),
(25), or (26) of subsection
(d) of |
4 |
| Section 204, or an analog or derivative thereof;
|
5 |
| (C) not less than 8 years and not more than 40 |
6 |
| years with respect to: (i)
400
grams or more but
less |
7 |
| than 900 grams of any substance listed in paragraph |
8 |
| (1), (2), (2.1), (2.2), (3),
(14.1), (19), (20),
|
9 |
| (20.1), (21), (25), or (26) of subsection (d) of |
10 |
| Section 204, or an analog or
derivative thereof,
or |
11 |
| (ii) 600 or more pills, tablets, caplets, capsules, or |
12 |
| objects but less than
1,500 pills, tablets,
caplets, |
13 |
| capsules, or objects containing in them or having upon |
14 |
| them any amount
of any
substance listed in paragraph |
15 |
| (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), |
16 |
| (20.1),
(21), (25), or (26) of
subsection (d) of |
17 |
| Section 204, or an analog or derivative thereof;
|
18 |
| (D) not less than 10 years and not more than 50 |
19 |
| years with respect to:
(i)
900 grams or more of
any |
20 |
| substance listed in paragraph (1), (2), (2.1), (2.2), |
21 |
| (3), (14.1), (19), (20),
(20.1), (21), (25), or (26)
of |
22 |
| subsection (d) of Section 204, or an analog or |
23 |
| derivative thereof, or (ii)
1,500 or more pills,
|
24 |
| tablets, caplets, capsules, or objects containing in |
25 |
| them or having upon them
any amount of a
substance |
26 |
| listed in paragraph (1), (2), (2.1), (2.2), (3), |
|
|
|
HB0445 Enrolled |
- 30 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| (14.1), (19), (20), (20.1),
(21), (25), or (26) of
|
2 |
| subsection (d) of Section 204, or an analog or |
3 |
| derivative thereof;
|
4 |
| (8) 30 grams or more of any substance containing |
5 |
| pentazocine or any of
the salts, isomers and salts of |
6 |
| isomers of pentazocine, or an analog thereof;
|
7 |
| (9) 30 grams or more of any substance containing |
8 |
| methaqualone or any
of the salts, isomers and salts of |
9 |
| isomers of methaqualone;
|
10 |
| (10) 30 grams or more of any substance containing |
11 |
| phencyclidine or any
of the salts, isomers and salts of |
12 |
| isomers of phencyclidine (PCP);
|
13 |
| (10.5) 30 grams or more of any substance containing |
14 |
| ketamine or any of
the salts, isomers and salts of isomers |
15 |
| of ketamine;
|
16 |
| (11) 200 grams or more of any substance containing any |
17 |
| substance
classified as a narcotic drug in Schedules I or |
18 |
| II, or an analog thereof, which is not otherwise
included |
19 |
| in this subsection.
|
20 |
| (b) Any person sentenced with respect to violations of |
21 |
| paragraph (1),
(2), (3), (7), or (7.5) of subsection (a) |
22 |
| involving 100
grams or more of the
controlled substance named |
23 |
| therein, may in addition to the penalties
provided therein, be |
24 |
| fined an amount not to exceed $200,000 or the full
street value |
25 |
| of the controlled or counterfeit substances, whichever is
|
26 |
| greater. The term "street value" shall have the meaning
|
|
|
|
HB0445 Enrolled |
- 31 - |
LRB096 04780 RLC 14844 b |
|
|
1 |
| ascribed in Section 110-5 of the Code of Criminal Procedure of |
2 |
| 1963. Any
person sentenced with respect to any other provision |
3 |
| of subsection (a), may
in addition to the penalties provided |
4 |
| therein, be fined an amount not to
exceed $200,000.
|
5 |
| (c) Any person who violates this Section with regard to an |
6 |
| amount
of a controlled substance other than methamphetamine or |
7 |
| counterfeit substance not set forth in
subsection (a) or (d) is |
8 |
| guilty of a Class 4 felony. The fine for a
violation punishable |
9 |
| under this subsection (c) shall not be more
than $25,000.
|
10 |
| (d) Any person who violates this Section with regard to any |
11 |
| amount of
anabolic steroid is guilty of a Class C misdemeanor
|
12 |
| for the first offense and a Class B misdemeanor for a |
13 |
| subsequent offense
committed within 2 years of a prior |
14 |
| conviction.
|
15 |
| (Source: P.A. 94-324, eff. 7-26-05; 94-556, eff. 9-11-05; |
16 |
| 95-331, eff. 8-21-07.)
|